333 related articles for article (PubMed ID: 36745422)
1. Deprescribing Medications Among Older Adults From End of Hospitalization Through Postacute Care: A Shed-MEDS Randomized Clinical Trial.
Vasilevskis EE; Shah AS; Hollingsworth EK; Shotwell MS; Kripalani S; Mixon AS; Simmons SF
JAMA Intern Med; 2023 Mar; 183(3):223-231. PubMed ID: 36745422
[TBL] [Abstract][Full Text] [Related]
2. A patient-centered deprescribing intervention for hospitalized older patients with polypharmacy: rationale and design of the Shed-MEDS randomized controlled trial.
Vasilevskis EE; Shah AS; Hollingsworth EK; Shotwell MS; Mixon AS; Bell SP; Kripalani S; Schnelle JF; Simmons SF;
BMC Health Serv Res; 2019 Mar; 19(1):165. PubMed ID: 30871561
[TBL] [Abstract][Full Text] [Related]
3. The MedSafer Study-Electronic Decision Support for Deprescribing in Hospitalized Older Adults: A Cluster Randomized Clinical Trial.
McDonald EG; Wu PE; Rashidi B; Wilson MG; Bortolussi-Courval É; Atique A; Battu K; Bonnici A; Elsayed S; Wilson AG; Papillon-Ferland L; Pilote L; Porter S; Murphy J; Ross SB; Shiu J; Tamblyn R; Whitty R; Xu J; Fabreau G; Haddad T; Palepu A; Khan N; McAlister FA; Downar J; Huang AR; MacMillan TE; Cavalcanti RB; Lee TC
JAMA Intern Med; 2022 Mar; 182(3):265-273. PubMed ID: 35040926
[TBL] [Abstract][Full Text] [Related]
4. Shed-MEDS: pilot of a patient-centered deprescribing framework reduces medications in hospitalized older adults being transferred to inpatient postacute care.
Petersen AW; Shah AS; Simmons SF; Shotwell MS; Jacobsen JML; Myers AP; Mixon AS; Bell SP; Kripalani S; Schnelle JF; Vasilevskis EE
Ther Adv Drug Saf; 2018 Sep; 9(9):523-533. PubMed ID: 30181860
[TBL] [Abstract][Full Text] [Related]
5. Deprescribing Education vs Usual Care for Patients With Cognitive Impairment and Primary Care Clinicians: The OPTIMIZE Pragmatic Cluster Randomized Trial.
Bayliss EA; Shetterly SM; Drace ML; Norton JD; Maiyani M; Gleason KS; Sawyer JK; Weffald LA; Green AR; Reeve E; Maciejewski ML; Sheehan OC; Wolff JL; Kraus C; Boyd CM
JAMA Intern Med; 2022 May; 182(5):534-542. PubMed ID: 35343999
[TBL] [Abstract][Full Text] [Related]
6. The OPTIMIZE patient- and family-centered, primary care-based deprescribing intervention for older adults with dementia or mild cognitive impairment and multiple chronic conditions: study protocol for a pragmatic cluster randomized controlled trial.
Bayliss EA; Shetterly SM; Drace ML; Norton J; Green AR; Reeve E; Weffald LA; Wright L; Maciejewski ML; Sheehan OC; Wolff JL; Gleason KS; Kraus C; Maiyani M; Du Vall M; Boyd CM
Trials; 2020 Jun; 21(1):542. PubMed ID: 32552857
[TBL] [Abstract][Full Text] [Related]
7. Association of Deprescribing With Reduction in Mortality and Hospitalization: A Pragmatic Stepped-Wedge Cluster-Randomized Controlled Trial.
Kua CH; Yeo CYY; Tan PC; Char CWT; Tan CWY; Mak V; Leong IY; Lee SWH
J Am Med Dir Assoc; 2021 Jan; 22(1):82-89.e3. PubMed ID: 32423694
[TBL] [Abstract][Full Text] [Related]
8. Family Conferences to Facilitate Deprescribing in Older Outpatients With Frailty and With Polypharmacy: The COFRAIL Cluster Randomized Trial.
Mortsiefer A; Löscher S; Pashutina Y; Santos S; Altiner A; Drewelow E; Ritzke M; Wollny A; Thürmann P; Bencheva V; Gogolin M; Meyer G; Abraham J; Fleischer S; Icks A; Montalbo J; Wiese B; Wilm S; Feldmeier G
JAMA Netw Open; 2023 Mar; 6(3):e234723. PubMed ID: 36972052
[TBL] [Abstract][Full Text] [Related]
9. Impact of a pharmacist-administered deprescribing intervention on nursing home residents: a randomized controlled trial.
Balsom C; Pittman N; King R; Kelly D
Int J Clin Pharm; 2020 Aug; 42(4):1153-1167. PubMed ID: 32494991
[TBL] [Abstract][Full Text] [Related]
10. Patient-Reported Barriers and Enablers to Deprescribing Recommendations During a Clinical Trial (Shed-MEDS).
Kim JL; Lewallen KM; Hollingsworth EK; Shah AS; Simmons SF; Vasilevskis EE
Gerontologist; 2023 Mar; 63(3):523-533. PubMed ID: 35881109
[TBL] [Abstract][Full Text] [Related]
11. The MedSafer Study: A Controlled Trial of an Electronic Decision Support Tool for Deprescribing in Acute Care.
McDonald EG; Wu PE; Rashidi B; Forster AJ; Huang A; Pilote L; Papillon-Ferland L; Bonnici A; Tamblyn R; Whitty R; Porter S; Battu K; Downar J; Lee TC
J Am Geriatr Soc; 2019 Sep; 67(9):1843-1850. PubMed ID: 31250427
[TBL] [Abstract][Full Text] [Related]
12. Spread and scale of an electronic deprescribing software to improve health outcomes of older adults living in nursing homes: study protocol for a stepped wedge cluster randomized trial.
Nadeau ME; Henry JL; Lee TC; Bortolussi-Courval É; Goodine C; McDonald EG
Trials; 2021 Nov; 22(1):763. PubMed ID: 34727956
[TBL] [Abstract][Full Text] [Related]
13. Deprescribing for older people living in residential aged care facilities: Pharmacist recommendations, doctor acceptance and implementation.
Quek HW; Etherton-Beer C; Page A; McLachlan AJ; Lo SY; Naganathan V; Kearney L; Hilmer SN; Comans T; Mangin D; Lindley RI; Potter K
Arch Gerontol Geriatr; 2023 Apr; 107():104910. PubMed ID: 36565605
[TBL] [Abstract][Full Text] [Related]
14. Medication Discrepancies Among Older Hospitalized Adults Discharged From Post-Acute Care Facilities to Home.
Vasilevskis EE; Trumbo SP; Shah AS; Hollingsworth EK; Shotwell MS; Mixon AS; Simmons SF
J Am Med Dir Assoc; 2024 May; ():105017. PubMed ID: 38754476
[TBL] [Abstract][Full Text] [Related]
15. Deprescribing to reduce polypharmacy: study protocol for a randomised controlled trial assessing deprescribing of anticholinergic and sedative drugs in a cohort of frail older people living in the community.
Bergler U; Ailabouni NJ; Pickering JW; Hilmer SN; Mangin D; Nishtala PS; Jamieson H;
Trials; 2021 Nov; 22(1):766. PubMed ID: 34732234
[TBL] [Abstract][Full Text] [Related]
16. Pharmacist-led medication review in a residential in-reach service leads to deprescribing.
Hui JH; Parikh S; Kouladjian O'Donnell L; Mcinerney B; Dillon L; Poojary S; Crabtree A
Australas J Ageing; 2023 Dec; 42(4):675-682. PubMed ID: 37198738
[TBL] [Abstract][Full Text] [Related]
17. Pharmacist-led medication assessment and deprescribing intervention for older adults with cancer and polypharmacy: a pilot study.
Whitman A; DeGregory K; Morris A; Mohile S; Ramsdale E
Support Care Cancer; 2018 Dec; 26(12):4105-4113. PubMed ID: 29869294
[TBL] [Abstract][Full Text] [Related]
18. Impact of deprescribing rounds on discharge prescriptions: an interventional trial.
Edey R; Edwards N; Von Sychowski J; Bains A; Spence J; Martinusen D
Int J Clin Pharm; 2019 Feb; 41(1):159-166. PubMed ID: 30478496
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of Bundled Hyperpolypharmacy Deprescribing Compared With Usual Care Among Older Adults: A Randomized Clinical Trial.
Herrinton LJ; Lo K; Alavi M; Alexeeff SE; Butler KM; Chang C; Chang CC; Chu VL; Krishnaswami A; Deguzman LH; Prausnitz S; Mason MD; Draves M
JAMA Netw Open; 2023 Jul; 6(7):e2322505. PubMed ID: 37428504
[TBL] [Abstract][Full Text] [Related]
20. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
